Is Kura Oncology, Inc. (KURA) a Buy, Sell, or Hold?
NASDAQ : KURA
Kura Oncology, Inc. — Institutional Ownership
$9.04 USD
$0.11 (1.23%)
- Volume
- 115.64K
- Average Volume
- 1.74M
- Market Capitalization
- $802.52M
- P/E Ratio
- -2.70
- Dividend Yield
- 0.00%
- Price Target
- $24.00
- Year High
- $12.49
- Year Low
- $5.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.15
Institutional Ownership Summary
Institutional Ownership %
3.63%
Investors Holding
39
change: -187 | last: 226
Increased Positions
23
change: -82 | last: 105
Reduced Positions
9
change: -73 | last: 82
New Positions
6
change: -30 | last: 36
Sold Positions
185
change: 155 | last: 30
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -99.908 | last: 0.9991
Total Invested
35.11M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Armistice Capital, LLC | 3.74M | 4.23% |
| 2026-04-30 | Vanguard Capital Management | 4.43M | 5.01% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Armistice Capital, LLC | 4.94M | 5.67% |
| 2026-02-09 | STATE STREET CORPORATION | 4.93M | 5.70% |
| 2025-11-14 | BIOTECHNOLOGY VALUE FUND L P | 4.42M | 5.10% |
| 2025-11-14 | Armistice Capital, LLC | 4.67M | 5.37% |
| 2025-08-15 | Armistice Capital, LLC | 6.2M | 7.14% |
| 2025-08-14 | EcoR1 Capital, LLC | 4.2M | 4.80% |
| 2025-05-15 | RA Capital Management, L.P. | 4M | 4.90% |
| 2025-05-15 | Armistice Capital, LLC | 6.57M | 7.59% |
| 2025-05-02 | SUVRETTA CAPITAL MANAGEMENT, LLC | 7.56M | 9.40% |
| 2025-04-17 | BlackRock, Inc. | 6.33M | 7.80% |
| 2025-02-14 | Paradigm BioCapital Advisors LP | - | 0.00% |
| 2025-02-14 | Armistice Capital, LLC | 5.8M | 7.46% |
| 2025-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | 5.2M | 6.70% |
| 2025-02-13 | Deerfield Mgmt, L.P. | - | 0.00% |
| 2025-02-04 | BIOTECHNOLOGY VALUE FUND L P | 1.75M | 2.20% |
| 2025-02-04 | BIOTECHNOLOGY VALUE FUND L P | 3.04M | 3.90% |
| 2025-01-08 | BlackRock, Inc. | 7.93M | 10.20% |
| 2024-12-05 | Peter Kolchinsky | 4.37M | 5.60% |
| 2024-12-05 | RA Capital Management, L.P. | 4.37M | 5.60% |
| 2024-12-05 | RA Capital Healthcare Fund, L.P. | 4.37M | 5.60% |
| 2024-12-05 | Rajeev Shah | 4.37M | 5.60% |
| 2024-05-02 | Paradigm BioCapital Advisors LP | 3.86M | 5.10% |
| 2023-09-21 | Deerfield Management Company, L.P. | 4.37M | 5.89% |
| 2023-09-21 | Deerfield Mgmt, L.P. | 4.37M | 5.89% |
| 2023-09-21 | Deerfield Partners, L.P. | 4.37M | 5.89% |
| 2023-09-21 | James E. Flynn | 4.37M | 5.89% |
| 2022-12-05 | Mark N. Lampert | 3.55M | 5.30% |
| 2022-12-05 | BVF I GP LLC | 1.83M | 2.70% |
| 2022-12-05 | BVF Partners L.P. | 3.55M | 5.30% |
| 2022-12-05 | BVF Inc. | 3.55M | 5.30% |
| 2022-12-05 | BVF GP Holdings LLC | 3.33M | 5.00% |
| 2022-12-05 | BVF Partners OS Ltd. | 161.42K | 1.00% |
| 2022-12-05 | Biotechnology Value Fund II, L.P. | 1.5M | 2.30% |
| 2022-12-05 | Biotechnology Value Fund, L.P. | 1.83M | 2.70% |
| 2022-12-05 | BVF II GP LLC | 1.5M | 2.30% |
| 2022-12-05 | Biotechnology Value Trading Fund OS LP | 161.42K | 1.00% |
| 2022-02-11 | Suvretta Capital Management, LLC | 3.57M | 5.40% |
| 2022-02-11 | Aaron Cowen | 3.57M | 5.40% |
| 2022-02-11 | Averill Master Fund, Ltd. | 3.57M | 5.40% |
| 2022-02-11 | STATE STREET CORPORATION | 3.38M | 5.08% |
| 2022-02-04 | David Kroin | 3.36M | 5.05% |
| 2022-02-04 | Deep Track Capital, LP | 3.36M | 5.05% |
| 2022-02-04 | Deep Track Biotechnology Master Fund, Ltd. | 3.36M | 5.05% |
| 2022-01-31 | EcoR1 Capital Fund Qualified, L.P. | 4.13M | 11.00% |
| 2022-01-31 | EcoR1 Capital, LLC | 4.54M | 11.00% |
| 2022-01-31 | Oleg Nodelman | 4.54M | 11.00% |
| 2021-12-09 | Suvretta Capital Management, LLC | 3.5M | 5.30% |
| 2021-12-09 | Aaron Cowen | 3.5M | 5.30% |
| 2021-12-09 | Averill Master Fund, Ltd. | 3.5M | 5.30% |
| 2021-12-03 | Deerfield Partners, L.P. | 3.51M | 5.28% |
| 2021-12-03 | Company, L.P. | 3.51M | 5.28% |
| 2021-12-03 | James E. Flynn | 3.51M | 5.28% |
| 2021-12-03 | Deerfield Mgmt, L.P. | 3.51M | 5.28% |
| 2021-02-12 | Avoro Capital Advisors LLC | 4M | 6.20% |
| 2021-02-12 | Behzad Aghazadeh | 4M | 6.20% |
| 2021-02-11 | Mark N. Lampert | 1.25M | 1.90% |
| 2021-02-11 | BVF Partners OS Ltd. | 80458.0 | 1.00% |
| 2021-02-11 | Biotechnology Value Trading Fund OS LP | 80458.0 | 1.00% |
| 2021-02-11 | BVF Partners L.P. | 1.25M | 1.90% |
| 2021-02-11 | BVF Inc. | 1.25M | 1.90% |
| 2021-02-11 | Biotechnology Value Fund, L.P. | 662.29K | 1.00% |
| 2021-02-11 | BVF II GP LLC | 479.52K | 1.00% |
| 2021-02-11 | BVF I GP LLC | 662.29K | 1.00% |
| 2021-02-11 | Biotechnology Value Fund II, L.P. | 479.52K | 1.00% |
| 2021-02-11 | BVF GP HOLDINGS LLC | 1.14M | 1.70% |
| 2021-01-29 | (1) BlackRock, Inc. | 4.93M | 7.60% |
| 2021-01-28 | Troy Edward Wilson | 2.19M | 3.30% |
| 2020-03-16 | Biotechnology Value Trading Fund OS LP | 169.02K | 1.00% |
| 2020-03-16 | BVF Partners OS Ltd. | 169.02K | 1.00% |
| 2020-03-16 | BVF Inc. | 2.43M | 5.40% |
| 2020-03-16 | BVF II GP LLC | 934.68K | 2.10% |
| 2020-03-16 | BVF Partners L.P. | 2.43M | 5.40% |
| 2020-03-16 | Mark N. Lampert | 2.43M | 5.40% |
| 2020-03-16 | Biotechnology Value Fund, L.P. | 1.25M | 2.80% |
| 2020-03-16 | BVF GP HOLDINGS LLC | 2.19M | 4.80% |
| 2020-03-16 | BVF I GP LLC | 1.25M | 2.80% |
| 2020-03-16 | Biotechnology Value Fund II, L.P. | 934.68K | 2.10% |
| 2020-02-14 | BVF II GP LLC | 817.4K | 1.80% |
| 2020-02-14 | EcoR1 Capital, LLC | 4.24M | 11.00% |
| 2020-02-14 | EcoR1 Capital Fund Qualified, L.P. | 3.53M | 11.00% |
| 2020-02-14 | Mark N. Lampert | 2M | 4.40% |
| 2020-02-14 | BVF Partners L.P. | 2M | 4.40% |
| 2020-02-14 | Dr. Jeffrey R. Jay, M.D. | 853.78K | 1.88% |
| 2020-02-14 | Biotechnology Value Fund, L.P. | 975.57K | 2.20% |
| 2020-02-14 | Biotechnology Value Trading Fund OS LP | 140.72K | 1.00% |
| 2020-02-14 | Great Point Partners, LLC | 853.78K | 1.88% |
| 2020-02-14 | BVF I GP LLC | 975.57K | 2.20% |
| 2020-02-14 | Biotechnology Value Fund II, L.P. | 817.4K | 1.80% |
| 2020-02-14 | Oleg Nodelman | 4.24M | 11.00% |
| 2020-02-14 | BVF GP HOLDINGS LLC | 1.79M | 4.00% |
| 2020-02-14 | BVF Partners OS Ltd. | 140.72K | 1.00% |
| 2020-02-14 | Mr. David Kroin | 853.78K | 1.88% |
| 2020-02-14 | BVF Inc. | 2M | 4.40% |
| 2020-02-05 | (1) BlackRock, Inc. | 2.99M | 6.60% |
| 2020-01-31 | 2. | 2.37M | 5.24% |
| 2019-12-17 | 59-2385219 | 2.06M | 4.55% |
| 2019-02-13 | Abigail P. Johnson | 2.29M | 6.01% |
| 2019-02-13 | FMR LLC | 2.29M | 6.01% |
| 2019-02-13 | Select Biotechnology Portfolio | 2.29M | 6.01% |
| 2019-02-08 | (1) BlackRock, Inc. | 2.41M | 6.30% |
| 2019-01-30 | Troy Edward Wilson | 2.44M | 6.30% |
| 2019-01-15 | 59-2385219 | 2.03M | 5.35% |
| 2018-07-09 | BVF Partners OS Ltd. | 157.57K | 1.00% |
| 2018-07-09 | BVF Partners L.P. | 2.06M | 5.50% |
| 2018-07-09 | Biotechnology Value Trading Fund OS LP | 157.57K | 1.00% |
| 2018-07-09 | Biotechnology Value Fund II, L.P. | 694.54K | 1.90% |
| 2018-07-09 | Biotechnology Value Fund, L.P. | 1.01M | 2.70% |
| 2018-07-09 | BVF Inc. | 2.06M | 5.50% |
| 2018-07-09 | Mark N. Lampert | 2.06M | 5.50% |
| 2018-03-08 | (1) BlackRock, Inc. | 1.48M | 4.40% |
| 2018-02-01 | (1) BlackRock, Inc. | 1.52M | 5.00% |
| 2017-08-21 | Dr. Jeffrey R. Jay, M.D. | 1.64M | 5.92% |
| 2017-08-21 | Mr. David Kroin | 1.64M | 5.92% |
| 2017-08-21 | Great Point Partners, LLC | 1.64M | 5.92% |
| 2017-02-03 | of 5 Pages | 21.81M | 10.20% |
| 2016-02-16 | Robert Nelsen | 1.89M | 8.80% |
| 2016-02-16 | ARCH Venture Partners VIII, L.P. | 1.89M | 8.80% |
| 2016-02-16 | Keith Crandell | 1.89M | 8.80% |
| 2016-02-16 | Clinton Bybee | 1.89M | 8.80% |
| 2016-02-16 | ARCH Venture Fund VIII, L.P. | 1.89M | 8.80% |
| 2016-02-16 | ARCH Venture Partners VIII, LLC | 1.89M | 8.80% |
| 2016-01-27 | of 5 Pages | 2.14M | 10.03% |
| 2016-01-12 | 2. | 1.08M | 5.00% |
| 2016-01-12 | 2. | 1.08M | 5.00% |
| 2016-01-12 | 2. | 1.08M | 5.00% |
| 2016-01-12 | 2. | 1.08M | 5.00% |
| 2016-01-12 | 2. | 1.08M | 5.00% |
| 2015-04-10 | Select Biotechnology Portfolio | 1.52M | 10.48% |
| 2015-04-10 | Abigail P. Johnson | 1.85M | 12.73% |
| 2015-04-10 | Edward C. Johnson 3d | 1.85M | 12.73% |
| 2015-04-10 | FMR LLC | 1.85M | 12.73% |
| 2015-03-17 | BARCLAYS GLOBAL INVESTORS, NA. | 2.25M | 2.24% |
| 2015-03-13 | ARCH Venture Partners VIII, L.P. | 1.34M | 9.30% |
| 2015-03-13 | Robert Nelsen | 1.34M | 9.30% |
| 2015-03-13 | Clinton Bybee | 1.34M | 9.30% |
| 2015-03-13 | ARCH Venture Fund VIII, L.P. | 1.34M | 9.30% |
| 2015-03-13 | ARCH Venture Partners VIII, LLC | 1.34M | 9.30% |
| 2015-03-13 | Keith Crandell | 1.34M | 9.30% |
KURA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $10.39 | 87.68M | $910.95M | $149.1M | $20.46M | $782.31M |
| 2024-12-31 | $8.71 | 86.16M | $750.46M | $224.46M | $16.59M | $542.59M |
| 2023-12-31 | $14.38 | 73.23M | $1.05B | $37.32M | $17.2M | $1.03B |
| 2022-12-31 | $12.41 | 66.99M | $831.35M | $51.8M | $14.02M | $793.57M |
| 2021-12-31 | $14.00 | 66.35M | $928.93M | $90.67M | $6.88M | $845.13M |
| 2020-12-31 | $32.66 | 53.08M | $1.73B | $325.49M | $14.98M | $1.42B |
| 2019-12-31 | $13.75 | 41.95M | $576.76M | $26.14M | $7.75M | $558.37M |
| 2018-12-31 | $14.04 | 35.19M | $494.08M | $16.12M | $7.5M | $485.46M |
| 2017-12-31 | $15.30 | 23.24M | $355.53M | $11.43M | $7.1M | $351.19M |
| 2016-12-31 | $5.90 | 18.7M | $110.34M | $9.72M | $7.32M | $107.93M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8.13 | 88.61M | $720.4M | $39.08M | $24.27M | $705.59M |
| 2025-12-31 | $10.39 | 88.05M | $914.84M | $149.1M | $20.46M | $786.2M |
| 2025-09-30 | $8.85 | 87.65M | $775.66M | $95.29M | $19.47M | $699.84M |
| 2025-06-30 | $5.77 | 87.59M | $505.37M | $81.95M | $19.47M | $442.9M |
| 2025-03-31 | $6.60 | 87.42M | $576.94M | $51.27M | $19.35M | $545.02M |
| 2024-12-31 | $8.71 | 87.14M | $758.95M | $224.46M | $16.59M | $551.09M |
| 2024-09-30 | $19.54 | 86.95M | $1.7B | $49.48M | $16.63M | $1.67B |
| 2024-06-30 | $21.20 | 86.64M | $1.84B | $45.18M | $16.73M | $1.81B |
| 2024-03-31 | $21.82 | 83.9M | $1.83B | $41.51M | $16.97M | $1.81B |
| 2023-12-31 | $14.38 | 77.34M | $1.11B | $37.32M | $17.2M | $1.09B |
| 2023-09-30 | $9.12 | 77.24M | $704.44M | $28.74M | $17.42M | $693.12M |
| 2023-06-30 | $10.58 | 69.8M | $738.43M | $49.12M | $13.04M | $702.35M |